Cyclooxygenase (COX)-2 Selective and Non-Selective Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Risk of Hyperkalemia

被引：0
|
作者：
Lafrance, Jean-Philippe [1 ,2 ]
Miller, Donald R. [1 ,2 ]
机构：
[1] Boston Univ, Sch Publ Hlth, Boston, MA USA
[2] VA Med Ctr, Bedford, MA USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2010年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
258
引用
收藏
页码：S110 / S111
页数：2
相关论文
共 50 条
  • [41] Safety of Oral Non-Selective Non-Steroidal Anti-Inflammatory Drugs in Osteoarthritis: What Does the Literature Say?
    Cyrus Cooper
    Roland Chapurlat
    Nasser Al-Daghri
    Gabriel Herrero-Beaumont
    Olivier Bruyère
    François Rannou
    Roland Roth
    Daniel Uebelhart
    Jean-Yves Reginster
    Drugs & Aging, 2019, 36 : 15 - 24
  • [42] Safety of Oral Non-Selective Non-Steroidal Anti-Inflammatory Drugs in Osteoarthritis: What Does the Literature Say?
    Cooper, Cyrus
    Chapurlat, Roland
    Al-Daghri, Nasser
    Herrero-Beaumont, Gabriel
    Bruyere, Olivier
    Rannou, Francois
    Roth, Roland
    Uebelhart, Daniel
    Reginster, Jean-Yves
    DRUGS & AGING, 2019, 36 (Suppl 1) : 15 - 24
  • [43] Are COX-2 inhibitors preferable to non-selective non-steroidal anti-inflammatory drugs in patients with risk of cardiovascular events taking low-dose aspirin?
    Strand, Vibeke
    LANCET, 2007, 370 (9605): : 2138 - 2151
  • [44] Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: A critical review of non-selective COX-2 blockade (review)
    Harris, RE
    Beebe-Donk, J
    Doss, H
    Doss, DB
    ONCOLOGY REPORTS, 2005, 13 (04) : 559 - 583
  • [45] The risk of congestive heart failure with non-steroidal anti-inflammatory drugs and selective cyclooxygenase-2 inhibitors - A class effect?
    Hudson, M
    Rahme, E
    Richard, H
    Pilote, L
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S402 - S402
  • [46] Cyclooxygenase selectivity of non-steroidal anti-inflammatory drugs (nSAIDs) in humans:: Ex vivo evaluation
    Giuliano, F
    Vojnovic, I
    De Nucci, G
    Warner, TD
    BRITISH JOURNAL OF PHARMACOLOGY, 2000, 129 : U57 - U57
  • [47] Less gasstrointestinal risk, similar cardiovascular risk among users of selective compared to non-selective non steroidal anti-inflammatory drugs
    van der Linden, Michiel W.
    van der Bij, Sjoukje
    Welsing, Paco
    Kuipers, Ernst J.
    Herings, Ron M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 : S216 - S217
  • [48] Comparison of gastrointestinal adverse effects between cyclooxygenase-2 inhibitors and non-selective, non-steroidal anti-inflammatory drugs plus proton pump inhibitors
    Lai, Shih-Wei
    Liao, Kuan-Fu
    JOURNAL OF GASTROENTEROLOGY, 2013, 48 (05) : 674 - 674
  • [49] Comparison of gastrointestinal adverse effects between cyclooxygenase-2 inhibitors and non-selective, non-steroidal anti-inflammatory drugs plus proton pump inhibitors
    Shih-Wei Lai
    Kuan-Fu Liao
    Journal of Gastroenterology, 2013, 48 : 674 - 674
  • [50] Platelet function is inhibited by non-selective non-steroidal anti-inflammatory drugs but not by cyclo-oxygenase-2-selective inhibitors in patients with rheumatoid arthritis
    Knijff-Dutmer, EAJ
    Kalsbeek-Batenburg, EM
    Koerts, J
    van de Laar, MAFJ
    RHEUMATOLOGY, 2002, 41 (04) : 458 - 461
12345